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Abstract
We have previously reported that hydrogen sulfide (H2S), a gasotransmitter and vasodilator has cytoprotective properties
against methylglyoxal (MG), a reactive glucose metabolite associated with diabetes and hypertension. Recently, H2S was
shown to up-regulate peroxisome proliferator-activated receptor-c coactivator (PGC)-1a, a key gluconeogenic regulator that
enhances the gene expression of the rate-limiting gluconeogenic enzyme, fructose-1,6-bisphosphatase (FBPase). Thus, we
sought to determine whether MG levels and gluconeogenic enzymes are altered in kidneys of 6–22 week-old cystathionine
c-lyase knockout (CSE
-/-;H 2S-producing enzyme) male mice. MG levels were determined by HPLC. Plasma glucose levels
were measured by an assay kit. Q-PCR was used to measure mRNA levels of PGC-1a and FBPase-1 and -2. Coupled-
enzymatic assays were used to determine FBPase activity, or triosephosphate levels. Experimental controls were either age-
matched wild type mice or untreated rat A-10 cells. Interestingly, we observed a significant decrease in plasma glucose
levels along with a significant increase in plasma MG levels in all three age groups (6–8, 14–16, and 20–22 week-old) of the
CSE
-/- mice. Indeed, renal MG and triosephosphates were increased, whereas renal FBPase activity, along with its mRNA
levels, were decreased in the CSE
-/- mice. The decreased FBPase activity was accompanied by lower levels of its product,
fructose-6-phosphate, and higher levels of its substrate, fructose-1,6-bisphosphate in renal extracts from the CSE
-/- mice. In
agreement, PGC-1a mRNA levels were also significantly down-regulated in 6-22 week-old CSE
-/- mice. Furthermore, FBPase-
1 and -2 mRNA levels were reduced in aorta tissues from CSE
-/- mice. Administration of NaHS, a H2S donor, increased the
gene expression of PGC-1a and FBPase-1 and -2 in cultured rat A-10 cells. In conclusion, overproduction of MG in CSE
-/- mice
is due to a H2S-mediated down-regulation of the PGC-1a-FBPase pathway, further suggesting the important role of H2Si n
the regulation of glucose metabolism and MG generation.
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Introduction
Hydrogen sulfide (H2S) is the most recent addition to the
endogenous gasotransmitter family that includes nitric oxide (NO)
and carbon monoxide (CO). H2S has remarkable vasodilatory [1],
anti-inflammatory [2], and anti-oxidant properties [3–5]. This
gasotransmitter is produced by cystathionine b-synthase, which is
predominantly expressed in the brain and CNS, cystathionine c-
lyase (CSE), the predominant H2S-producing enzyme in the
cardiovascular system [6], and by a newly identified enzyme, 3-
mercaptopyruvate sulfurtransferase localized in the brain [7] and
endothelium [8]. Recently, we showed that CSE deficiency and
reduced endogenous H2S production in vascular tissues resulted in
the development of hypertension in CSE
–/– mice [1].
Increased methylglyoxal (MG) has been linked to the develop-
ment of insulin resistance, type 2 diabetes mellitus (T2DM) [9,10],
as well as hypertension [11–15]. As a member of the reactive
carbonyl species, MG is formed mainly through the non-
enzymatic conversion of triosephosphates, such as dihydroxyace-
tone phosphate (DHAP) and glyceraldehyde 3-phosphate (GA3P)
[16,17]. The triosephosphate pool, in turn, is regulated by cellular
levels of glucose and fructose. Interestingly, recent studies showed
that plasma fructose level, not glucose, is more involved in MG
overproduction [14,17], which is mainly attributed to the over-
activated polyol pathway [17]. As such, the importance of
glycolysis in MG overproduction during hyperglycaemia is
questioned, because elevated levels of MG in the plasma, serum,
and aorta was shown to occur under normoglycemic conditions in
spontaneously hypertensive rats [13,14] and in Zucker obese rats
[17]. In our most recent study, we demonstrated that MG lowers
H2S concentrations in cultured vascular smooth muscle cells
(VSMCs) both directly by scavenging H2S and indirectly by down-
regulating CSE expression [3], suggesting an important interaction
between MG and H2S. As a reciprocal, it is likely that low H2S
levels may result in elevated MG levels.
The kidney plays a vital role in blood pressure regulation [18],
but its role in glucose metabolism is often ignored [19]. Indeed,
renal gluconeogenesis has been estimated to account for 2062%
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dramatically increased [19,20]. The rate of gluconeogenesis is
mainly regulated by the activities of certain unidirectional
enzymes, notably phosphoenolpyruvate carboxykinase (PEPCK),
fructose-1,6-bisphosphatase (FBPase), and glucose-6-phosphatase
[21]. Peroxisome proliferator-activated receptor-c coactivator
(PGC)-1a is a key regulator of energy metabolism [22] and is a
strong coactivator of PEPCK, FBPase, and the orphan nuclear
receptor estrogen-related receptor-a (ERRa), which in turn
mediates PGC-1a activity [23]. Interestingly, NO has been shown
to increase PGC-1a expression in adipocytes and HeLa cells [24],
and similar findings have been reported for CO in mouse hearts
[25]. However, it has yet to be determined if H2S can also alter
PGC-1a expression.
The present study investigated whether MG level was altered in
CSE
–/– mice and its underlying mechanisms. To this end, we
measured plasma and renal MG levels in both CSE
+/+ and
CSE
–/– mice at different age groups (6–22 weeks). We also
evaluated the role of FBPase and related signaling pathway in the
regulation of MG formation.
Materials and Methods
Animals and Tissue Preparation
Male 6–22 week-old CSE
+/+ and CSE
–/– mice (C57BL/6J x
129SvEv) were in-house bred as we described previously [1].
These animals were housed in a temperature-regulated animal
facility, exposed to a 12 h light/dark cycle with free access to food
and water. The Animal Health Care Committee of the University
of Saskatchewan specifically approved this animal study (protocol
number: 20030085). Prior to harvesting tissues, mice were starved
for 16 h. Kidneys and aortas were isolated in ice-cold PBS,
cleaned, and snap-frozen in liquid nitrogen immediately. Tissues
were pulverized with a Mikro-Dismembrator (B. Braun Biotech
International, PA, USA) and stored at 280uC until processing.
Cell culture
Rat aortic smooth muscle cell line (A-10 cells) was obtained
from American Type Culture Collection and cultured in
Dulbecco’s modified Eagle’s medium (DMEM) in a humidified
atmosphere of 95% air and 5% CO2 as described [3]. Cultured
cells were starved in serum-free DMEM for 24 h and exposed to
NaHS treatment for 24 h. Cells were then washed with ice-cold
PBS, harvested by trypsinization, and resuspended in cell lysis
buffer supplied by RNeasy Mini Kit (Qiagen sciences, MD, USA).
Plasma glucose measurement
Plasma glucose levels were determined by using the Quanti-
Chrom
TM Glucose Assay Kit (BioAssay Systems, USA), and
followed accordingly to the manufacturer’s instructions. Briefly,
5 mL of sample was mixed with 500 mL of Reagent, and then
placed on a heating block set at 100uC for 8 min. After cooled to
room temperature, samples were transferred to 96-well plate and
the absorbance was read at 630 nm in a Multiskan Spectrum
(Thermo Labsystems). Samples were measured in triplicate and
calibrated by comparison with the given manufacturer standards.
MG measurement
Quantitation of MG was performed by the widely accepted o-
phenylenediamine (o-PD)-based assay as described previously [26].
Kidney samples were prepared in 50 mM sodium phosphate
monobasic buffer (pH 4.5) and sonicated twice for 15 s on ice,
then centrifuged at 12,000 rpm at 4uC for 10 min. A portion of
the supernatant was used for protein determination via the
bicinchoninic acid (BCA) procedure. The supernatant of kidney
homogenate was incubated with a final concentration of 10 mM o-
PD (derivatizing agent) and 0.45 N perchloric acid (PCA) with
50 mM EDTA for 24 h at room temperature and protected from
light. The quinoxaline formed between dicarbonyl compounds
and o-PD, as well as the internal standard (5-methylquinoxaline)
were measured using a Hitachi D-7000 high performance liquid
chromatography (HPLC) system (Hitachi Ltd., Ontario, Canada).
A Nova-Pak C18 column was used (Waters, MA, USA). The
mobile phase was composed of 8% (v/v) of 50 mM NaH2PO4
(pH 4.5), 17% (v/v) of HPLC grade acetonitrile and 75% of water.
Samples were measured in triplicate and calibrated by comparison
with a 2-methylquinoxaline standard.
H2S measurement in plasma and kidney tissues
The measurement of renal H2S level followed the established
protocol in our laboratory [1,3,27,28]. Kidney homogenates were
suspended in 50 mM ice-cold potassium phosphate buffer
(pH 6.8) and added to a reaction mixture containing (mM): 100
potassium phosphate buffer (pH 7.4), 10 L-cysteine, and 2
pyridoxal-59-phosphate. The reaction was performed in a 25 mL
Erlenmeyer flask (Pyrex, USA). Cryovial test tubes (2 mL) were
used as the center wells containing 0.5 mL 1% zinc acetate as
trapping solution and filter paper (2 cm 6 2.5 cm) to increase
air:liquid contacting surface. The Erlenmeyer flasks containing the
reaction mixture and center wells were flushed with N2 gas before
being sealed with a double layer of parafilm. The reaction was
initiated by transferring the flasks from ice to a 37uC shaking water
bath. After incubating at 37uC for 90 min, 0.5 mL of 50%
trichloroacetic acid was added to terminate the reaction. The
flasks were incubated at 37uC for another 60 min to ensure a
complete trapping of released H2S gas from the mixture. Contents
of the center wells were then transferred to test tubes, each
containing 3.5 mL of double distilled water. Subsequently, 0.5 mL
of 20 mM N,N-dimethylphenylendiamine sulfate in 7.2 N HCl was
added immediately followed by addition of 0.5 mL 30 mM FeCl3
in 1.2 N HCl. The reaction mixture was incubated in the dark for
20 min at room temperature. The absorbance of the resulting
solution was measured at 670 nm in a Multiskan Spectrum
(Thermo Labsystems).
Measurement of plasma H2S concentration was performed as
described in pervious publications [29–31]. Aliquots of plasma
samples (100 mL) were mixed with 1% zinc acetate and 12%
NaOH (12%) and incubated in the dark for 15 min at room
temperature. Subsequently, double distilled water (pH 12.8),
20 mM N,N-dimethylphenylendiamine sulphate in 7.2 N HCl,
and 30 mM FeCl3 in 1.2 N HCl were added to the reaction
mixture and incubated in the dark for 15 min at room
temperature. The reactions were terminated by the addition of
10% trichloroacetic acid. Absorbance of the solution was
measured at a wavelength of 670 nm in a Multiskan Spectrum
(Thermo Labsystems). All samples were assayed in triplicate and
H2S concentration was calculated against a calibration curve of
NaHS.
Measurement of Enzyme Activities
To determine FBPase activity, kidney homogenates were added
to an assay mixture that contained 40 mM glycine buffer (pH 9.1),
1.0 mM EDTA, 2.0 mM MgCl2, 0.6 mM NADP
+, and 1.2 U/
mL of both glucose-6-phosphate dehydrogenase and phosphoglu-
cose isomerase. The reaction mixture was equilibrated for 10 min
at 37uC and initiated by the addition of 70 mM fructose-1,6-
bisphosphate (F-1,6-P) and the increase in absorbance was
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Labsystems), as described [32].
To determine phosphofructokinase (PFK) activity, kidney
homogenates were added to an assay mixture that contained
50 mM Tris buffer (pH 8.0), 1.0 mM EDTA, 5.0 mM MgCl2,
2.5 mM dithiothreitol, 0.2 mM NADH, 1.0 mM fructose-6-
phosphate (F-6-P), 1.5 U/mL aldolase, and 1.0 U/mL of both
triosephosphate isomerase and glycerophosphate dehydrogenase.
The reaction was initiated by the addition of 0.5 mM ATP and the
decrease in absorbance was measured at 340 nm in a Multiskan
Spectrum (Thermo Labsystems), as described [33].
RNA isolation and Real-time quantitative PCR
Total RNA was isolated using RNeasy Mini Kit (Qiagen
sciences, MD, USA) and followed accordingly to the manufactur-
er’s instructions. First strand cDNA was prepared from total RNA
(1 mg) by reverse transcription using iScript
TM cDNA Synthesis
Kit (Bio-Rad Laboratories, USA). Real-time quantitative PCR was
performed on the iCycler iQ Real-time PCR Detection System
(Bio-Rad, Nazareth). The primers specifically designed for mice
are listed in Table 1. The rat primers, PGC-1a, ERRa, FBPase-1
and -2, and b-actin were predesigned by Qiagen Inc. (ON,
Canada). The PCR conditions were as follows: denaturation at
95uC for 3 min, followed by 40 cycles of denaturation at 95uC for
30 s, annealing at 55uC for 1 min, and extension at 72uC for 30 s
as described [3,27,28]. Specificity of the amplification was
determined by melting curve analysis.
Triosephosphates, F-1,6-P, and F-6-P analyses
Kidney homogenates were acidified with the addition of 1 N
PCA (0.1 mM EDTA) for 5 min on ice, then centrifuged for 5 min
at 12,000 rpm at 4uC. The supernatant was neutralized with
2.5 M K2CO3 and left to vent for 5 min on ice and was later
centrifuged for 2 min at 12,000 rpm at 4uC. The supernatant was
used for the metabolite assays described below.
The assay mixture to determine renal triosephosphates (GA3P
and DHAP) and F-1,6-P levels contained 0.4 M triethanolamine
buffer (pH 7.6), 40 mM EDTA, 34 mM NADH, 0.095 U/mL
aldolase, 2.0 U/mL triosephosphate isomerase, and 0.3 U/mL
glycerophosphate dehydrogenase. The reaction was initiated by
the addition of the appropriate enzyme sequence and the decrease
in fluorescence was measured at 355/440 nm via Fluoroskan
Ascent (Thermo Labsystems) at as described [34].
The assay mixture to determine the renal level of F-6-P
contained 0.4 M triethanolamine buffer (pH 7.6), 1 mM EDTA,
5 mM MgCl2, 0.6 mM NADP
+, 1.0 U/mL glucose-6-phosphate
dehydrogenase, and 1.7 U/mL phosphoglucose isomerase. The
reaction was initiated by the addition of the appropriate enzyme
sequence and the increase in fluorescence was measured at 355/
440 nm via Fluoroskan Ascent (Thermo Labsystems) at as
described [35].
Chemicals and Data Analysis
All chemicals, primers, and enzymes used in this study were
obtained from Sigma-Aldrich (Sigma Aldrich, ON, Canada). The
data are expressed as mean 6 s.e.m. All values presented as a
percentage were normalized to the mean of age-matched CSE
+/+
mice or untreated cells. Statistical analyses were performed using
Student’s t test, and when applicable, the one-way ANOVA
followed by a post hoc analysis (Tukey’s test). Statistical significance
was considered at P,0.05.
Results
Reduced plasma glucose in 6-22 week-old CSE
-/- mice
The plasma glucose levels (mM) were significantly reduced by
18.64% in 6–8 (P,0.05), 21.94% in 14–16 (P,0.01) and 17.96%
in 20-22 (P,0.05) week-old CSE
-/- mice in comparison to their
age-matched WT mice under starvation conditions (16 h) (Fig. 1).
Table 1. Real-time PCR primer sequences for gene targets in mice.
Gene name Short name Forward primer 59-39 Reverse primer 59-39
Peroxisome proliferator-activated
receptor-c coactivator-1a
PGC-1a GGTACCCAAGGCAGCCACT GTGTCCTCGGCTGAGCACT
Phosphoenolpyruvate carboxykinase PEPCK ATCTTTGGTGGCCGTAGACCT GCCAGTGGGCCAGGTATTT
Estrogen-related receptor-a ERRa ATCTGCTGGTGGTTGAACCTG AGAAGCCTGGGATGCTCTTG
Fructose-1,6-bisphosphatase-1 FBPase-1 CAGGGACGTGAAGATGAAGAAGAA TTGTTGGCGGGGTATAAAAAGA
Fructose-1,6-bisphosphatase-2 FBPase-2 ACGTTATGGAAAAGGGGCGACAGG GCTCCCCGAAATCCCATACAGGTT
b-actin b-actin CCCATCTACGAGGGCTAT TGTCACGCACGATTTCC
doi:10.1371/journal.pone.0029592.t001
Figure 1. Plasma glucose levels in 6-22 week-old CSE
-/- mice.
Plasma glucose levels were measured in 6-8 (n=5–7), 14-16 (n=4–5),
and 20-22 (n=6–7) week-old CSE
-/- and CSE
+/+ mice after starving for
16 h. *P,0.05 and **P,0.01 vs. corresponding age-matched CSE
+/+
mice;
#P,0.05 vs. 6–8 week-old CSE
-/- mice;
{P,0.05 vs. 6–8 week-old
CSE
+/+ mice.
doi:10.1371/journal.pone.0029592.g001
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of age compared to 6–8 weeks of age in both CSE
-/- and CSE
+/+
mice (P,0.05).
Elevated MG and reduced H2S levels in plasma and renal
tissues in CSE
–/– mice
Plasma MG levels (mM) were significantly increased in CSE
–/–
mice by 28.28% in 6-8 (0.5960.03, P,0.05), 33.80% in 14-16
(0.6060.02, P,0.001), and 20.30% in 20-22 (1.8560.05,
P,0.001) week-old age groups with comparison to that from
age-matched CSE
+/+ groups (0.4660.05, 0.4260.01, and
1.5460.04; respectively) (Fig. 2A). In addition, plasma H2S levels
(mM) were significantly decreased by 47.76% in 6-8 (40.7764.78,
P,0.001), 43.40% in 14-16 (62.4064.79, P,0.01), and 40.94% in
20-24 (82.8166.69, P,0.05) week-old CSE
-/- mice compared to
age-matched CSE
+/+ mice (75.7963.57, 111.4168.98, and
131.96616.60; respectively) (Fig. 2B). Kidney MG levels
(nmoL/mg) were elevated by 11.41% in 6-8 (0.7860.01,
P,0.05), 15.40% in 14-16 (0.7660.02, P,0.01), and 25.67% in
20-22 (0.6860.01, P,0.001) week-old CSE
–/– mice compared to
that from age-matched CSE
+/+ mice (0.7060.02, 0.6660.03, and
0.5460.01; respectively) (Fig. 2C). Negatively correlated to renal
MG levels, kidney H2S production rate (nmoL/g/min) was
significantly reduced by 84.47% in 6-8 (2.7660.29, P,0.01),
85.61% in 14–16 (2.8860.25, P,0.01), and 75.95% in 20-22
(3.2360.46, P,0.01) week-old CSE
-/- mice compared to age-
matched CSE
+/+ mice (15.9861.16, 14.2261.74, and
13.3361.41; respectively) (Fig. 2D).
Impairment of FBPase activity and mRNA expression in 6-
22 week-old CSE
–/– mice
Total kidney FBPase activity (nmoL NADPH/min/mg) was
decreased by 12.74% in 6-8 (0.3060.02, P,0.05), 23.98% in 14–
16 (0.2260.01, P,0.05), and 36.12% in 20-22 (0.1660.01,
P,0.01) week-old CSE
–/– mice compared to age-matched
CSE
+/+ groups (0.3460.01, 0.2960.03, and 0.2460.01; respec-
Figure 2. Methylglyoxal and H2S levels in plasma and renal tissues in CSE
–/– mice. Panel A: Methylglyoxal (MG) levels in the plasma where
measured in 6-8 (n=7), 14-16 (n=4), and 20-22 (n=7) week-old CSE
-/- and CSE
+/+ mice. Panel B: H2S levels in plasma in 6-8 (n=4-6), 14-16 (n=4–6),
and 20-24 (n=3–5) week-old CSE
-/- and CSE
+/+ mice. Panel C: MG levels in renal tissues of 6-8 (n=5), 14-16 (n=6), and 20-22 (n=7) week-old mice.
Panel D: Renal H2S levels in 6-8 (n=3–5), 14-16 (n=4), and 20–22 (n=3-5) week-old mice. MG and H2S values from CSE
-/- mice are presented as a
percentage of the mean of age-matched CSE
+/+ mice. *P,0.05, **P,0.01, and ***P,0.001 vs. corresponding age groups of CSE
+/+ mice.
doi:10.1371/journal.pone.0029592.g002
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levels were decreased by 25.8066.64% in 6-8 (P,0.05),
51.1066.03% in 14-16 (P,0.001), and 63.9064.20% in 20-22
(P,0.001) week-old CSE
–/– mice compared to that from age-
matched CSE
+/+ group (Fig. 3B). Although FBPase-1 was reported
to be the dominant FBPase in the kidneys [36,37], in one group of
experiments we investigated whether FBPase-2 was expressed in
CSE
+/+ or altered in CSE
–/–. We observed that FBPase-2 mRNA
levels were expressed in both CSE
+/+ and CSE
–/– mice. The
mRNA levels of FBPase-2 were not changed in 6-8, but down-
regulated by 38.0569.12% in 14–16 (P,0.05) and 34.3366.34%
in 20-22 (P,0.05) week-old CSE
–/– mice compared to the control
mice (Fig. 3C).
Altered F-6-P, F-1,6-P, DHAP and GA3P levels in 6-22
week-old CSE
–/– mice
The levels of F-6-P (nmoL NADPH/min/mg), the product of
FBPase during gluconeogenesis, was decreased by 10.09% in 6-8
(1.5160.05, P,0.05), 11.56% in 14–16 (1.4960.03, P,0.01), and
16.07% in 20-22 (1.1460.03, P,0.001) week-old CSE
–/– mice in
comparison with that from age-matched CSE
+/+ groups
(1.6860.04, 1.6960.06, and 1.3660.04; respectively) (Fig. 4A).
In contrast, the levels of F-1,6-P (nmoL NADPH/10 min/mg), the
substrate of FBPase, was increased by 22.21% in 6-8 (1.6060.06,
P,0.01), 27.14% in 14-16 (1.4760.08, P,0.01), and 39.44% in
20-22 (1.5060.11, P,0.01) week-old CSE
-/- mice compared to
that from age-matched CSE
+/+ group (1.3160.06, 1.1660.08,
and 1.0760.05; respectively) (Fig. 4B). Likewise, the renal DHAP
and GA3P levels (nmoL NADH/10 min/mg), were also increased
in CSE
–/– mice by 24.10% in 6-8 (1.4460.06, P,0.001), 29.38%
in 14-16 (1.5560.09, P,0.001), and 47.14% in 20-22 (1.5560.08,
P,0.001) weeks old in comparison with that from age-matched
CSE
+/+ group (1.1660.04, 1.2060.04, and 1.0560.04; respec-
tively) (Fig. 4C). There was no change in the renal PFK activity, a
glycolytic enzyme that coverts F-6-P to F-1,6-P, in both the
CSE
–/– and CSE
+/+ group at different age groups (Fig. 4D).
Decreased mRNA expression of PGC-1a, PEPCK, and ERRa
in 6-22 week-old CSE
–/– mice
Since PGC-1a was reported to be a major contributor to
gluconeogenesis via the up-regulation of FBPase and PEPCK [21],
the gene expression level of PGC-1a was investigated in these
CSE
–/– mice. Interestingly, as shown in Fig. 5A, the mRNA levels
of renal PGC-1a were lowered by 38.5065.99% in 6-8 (P,0.05),
45.9066.55% in 14-16 (P,0.01), and 68.7869.35% in 20-22
(P,0.01) week-old age groups of CSE
–/– mice with comparison to
age-matched CSE
+/+ mice. Likewise, the renal mRNA levels of
one of the down-stream targets of PGC-1a, PEPCK, were also
decreased by 16.6064.52% in 6-8 (P,0.05), 28.2067.84% in 14-
16 (P,0.05), and 42.7065.18% in 20-22 (P,0.01) week-old
CSE
–/– mice in comparison to that from age-matched CSE
+/+
mice (Fig. 5B). Moreover, PGC-1a was also suggested to be a
strong coactivator of ERRa [23], thus we sought to determine
whether there was a corresponding fall in ERRa mRNA levels.
Indeed, we observed lower mRNA levels of ERRa in the CSE
–/–
mice by 27.7065.65% in 6-8 (P,0.05), 32.40610.10% in 14-16
Figure 3. Total fructose-1,6-bisphosphatase activity and fruc-
tose-1,6-bisphosphatase-1 and -2 mRNA levels in renal tissues
of CSE
–/– mice. Panel A: Total fructose-1,6-bisphosphatase (FBPase)
activity in kidneys of 6-8 (n=6), 14–16 (n=6), and 20-22 (n=4) week-old
mice. Panel B: Real-time PCR results of fructose-1,6-bisphosphatase
(FBPase)-1 levels in renal tissues of CSE
–/– mice ages 6-8 (n=5), 14–16
(n=7), and 20-22 (n=5) weeks. Panel C: Real-time PCR results of
FBPase-2 mRNA levels in kidneys of 6-8 (n=4), 14–16 (n=4), and 20-22
(n=5) week-old mice. FBPase activity, FBPase-1 and -2 mRNA values in
CSE
–/– mice are presented as a percentage of the mean of age-matched
CSE
+/+ mice. *P,0.05, **P,0.01, and ***P,0.001 vs. corresponding age
groups of CSE
+/+ mice.
doi:10.1371/journal.pone.0029592.g003
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compared to that from age-matched CSE
+/+ groups (Fig. 5C).
Down-regulation of FBPase-1 and -2 mRNA levels in aorta
of CSE
-/- mice
In correlation to the observed decreased in renal mRNA levels
of FBPase-1 and -2, we also reported a significant reduction of
mRNA levels of FBPase-1 by 36.9162.88% (P,0.01) and of
FBPase-2 by 41.38614.16% (P,0.05) in aorta tissues from 14-16
week-old CSE
-/- with comparison to that from age-matched
CSE
+/+ mice (Figs. 6A and B, respectively).
H2S-induced up-regulation of PGC-1a, FBPase-1 and -2,
and ERRa mRNA levels in A-10 cells
To determine if H2S directly up-regulated the gene expression
of PGC-1a, ERRa, FBPase-1 and -2, rat VSMCs (A-10 cells) were
subjected to different concentrations of NaHS, a H2S donor. We
observed an increase in the mRNA levels of PGC-1a by
53.03620.12% (P,0.05) and 69.21615.18% (P,0.01) in the
cells treated with 30 and 50 mM NaHS, respectively, in
comparison with that of untreated cells (Fig. 7A). Correspondingly,
we have also observed an up-regulation in the gene expression of
FBPase-1 by 63.1266.01% (P,0.05) in 30 mM NaHS- and
Figure 4. Fructose-6-phosphate, fructose-1,6-bisphosphate, and dihydroxyacetone phosphate and glyceraldehyde 3-phosphate
levels in renal tissues of CSE
–/– mice. Panel A: Fructose-6-phosphate (F-6-P) levels were measured in kidneys of 6-8 (n=6), 14–16 (n=6), and 20–
22 (n=6-8) week-old mice. Panel B: Fructose-1,6-bisphosphate (F-1,6-P) levels in kidneys were analyzed in 6-22 (n=5) week-old mice. Panel C: The
triosephosphates, dihydroxyacetone phosphate (DHAP) and glyceraldehyde 3-phosphate (GA3P), were measured in kidneys of 6-22 (n=5) week-old
mice. Panel D: Renal phosphofructokinase (PFK) activity was measured in 6-8 (n=4), 14–16 (n=4–5), 20-22 (n=4-5) week-old mice. The values from
CSE
-/- are presented as a percentage of the mean of age-matched CSE
+/+ mice. *P,0.05, **P,0.01, and ***P,0.001 vs. corresponding age groups of
CSE
+/+ mice.
doi:10.1371/journal.pone.0029592.g004
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along with FBPase-2 by 78.3266.24% (P,0.05) and ERRa by
61.2368.02% (P,0.05) in 50 mM NaHS-treated cells in compar-
ison to the untreated cells (Figs. 7C and D, respectively).
Discussion
The CSE
-/- mice are manifested with age-dependent hyperten-
sion [1] and increased proliferation of vascular smooth muscle cells
[31]. In our previous studies, we also showed that H2S production
was virtually eliminated in aortic tissues or smooth muscle cells
from CSE
-/- mice [1,31]. In the present study, we focused on the
Figure 5. mRNA levels of peroxisome proliferator-activated
receptor-c coactivator-1a, phosphoenolpyruvate carboxyki-
nase, and estrogen-related receptor-a in renal tissues of
CSE
–/– mice. Panel A: Peroxisome proliferator-activated receptor-c
coactivator (PGC)-1a mRNA levels in kidneys of CSE
–/– mice in 6-8
(n=5), 14–16 (n=6), and 20-22 (n=5) week-old mice. Panel B:
Phosphoenolpyruvate carboxykinase (PEPCK) mRNA in 6-8 (n=5), 14-16
(n=6), and 20-22 (n=5) week-old mice. Panel C: Estrogen-related
receptor-a (ERRa) mRNA in 6-8 (n=5), 14-16 (n=6), and 20-22 (n=5)
week-old mice. The mRNA values from CSE
–/– mice are presented as a
percentage of the mean of age-matched CSE
+/+ mice. *P,0.05 and
**P,0.01 vs. corresponding age groups of CSE
+/+ mice.
doi:10.1371/journal.pone.0029592.g005
Figure 6. mRNA levels of FBPase-1 and -2 in the aorta of 14-16
week-old CSE
-/- mice. FBPase-1 (Panel A) and -2 (Panel B) mRNA
expression levels were measured in aortic extracts from 14-16 week-old
CSE
–/– mice (n=3–4). The values from CSE
-/- are presented as a
percentage of the mean of age-matched CSE
+/+ mice. *P,0.05 and
**P,0.01 vs. 14-16 week-old CSE
+/+ mice.
doi:10.1371/journal.pone.0029592.g006
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We found that H2S production from renal tissues of CSE
-/- mice
was significantly suppressed in all three age groups (6–8, 14–16,
and 20–22 weeks). This suppression of H2S production was
accompanied by a parallel decrease in plasma glucose level, but
sharply contrasted by an age-dependent increase in kidney and
plasma MG levels in the CSE
-/- mice. Over the same observed age
spectrum, CSE
-/- mice exhibited increased renal triosephosphates
(DHAP and GA3P), the immediate precursors for MG formation
[38]. These data indicate that reduced H2S production is likely
linked to increased MG formation in the kidney of the CSE
-/-
mice. Our study points to the underlying mechanism for this
correlation to a down-regulated PGC-1a-FBPase signaling path-
way in the kidney. Not only the transcriptional expression of PGC-
1a and FBPase-1 and -2 was lower in CSE
-/- kidney, but also total
FBPase activity and its metabolic product (F-6-P) were decreased.
The importance of H2S level to the functionality of PGC-1a-
FBPase signaling pathway is beyond the kidney. In aortic tissues
from CSE
-/- mice, with low endogenous H2S production [31],
lower mRNA levels of FBPase-1 and -2 were observed. On the
other hand, the treatment of cultured rat aortic A-10 cells with an
exogenous H2S donor, NaHS, significantly up-regulated the
expression of PGC-1a, FBPase-1 and -2, and ERRa.
It has been extensively studied that abnormally high levels of
H2S may be linked to T2DM and insulin-resistance [39–42],
which could mainly be accredited to its ability to inhibit both
insulin secretion from pancreatic b-cells [27,43–45] and glucose-
uptake into adipocytes [46]. Consequently, one would assume that
this would affect the overall circulating glucose levels, where high
H2S levels could lead to high systemic glucose levels. On the other
hand, lower levels of H2S in the circulation and specific tissues are
expected in favour of reducing plasma glucose levels and
postponing the development of diabetes. Indeed, we have observed
significantly lower plasma glucose levels (Fig. 1), as well as plasma
H2S levels (Fig. 2B) in all three age groups of the CSE
-/- mice.
Moreover, our recent study has reported that CSE
-/- mice that
received streptozotocin injections exhibited a delayed onset of
diabetic status (hyperglycaemia, hypoinsulinemia, and glucose
intolerance), in comparison with wild type mice [28]. Thus, these
findings further support the involvement of the CSE/H2S system
in glucose regulation.
This is the first study to show that MG levels are elevated under
reduced gluconeogenic conditions in plasma and renal tissues of
the CSE knockout mice (Figs. 2A and C, respectively). The
elevated renal MG levels, in turn, appear to be accounted for by
the elevated renal levels of the MG precursors, DHAP and GA3P
Figure 7. mRNA levels of proliferator-activated receptor-c coactivator-1a, fructose-1,6-bisphosphatase-1 and -2, and estrogen-
related receptor-a in NaHS-treated rat A-10 cells. Rat A-10 cells were treated with NaHS at different concentrations for 24 h to determine
mRNA levels of proliferator-activated receptor-c coactivator (PGC)-1a (Panel A), fructose-1,6-bisphosphatase (FBPase)-1 (Panel B), FBPase-2 (Panel
C), and estrogen-related receptor-a (ERRa) (Panel D). n=5 for each group in Panels A, B, C, and D. The mRNA values obtained from NaHS-treated
A-10 cells are presented as a percentage of the mean of control cells. *P,0.05 and **P,0.01 vs. control group.
doi:10.1371/journal.pone.0029592.g007
Increased Renal MG Formation in CSE
-/- Mice
PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e29592(Fig. 4C). This increased MG formation in kidneys of CSE
knockout mice is important, as we have shown that elevated MG
levels in kidneys of spontaneously hypertensive rats lead to
increased advanced glycation endproducts formation and oxida-
tive stress [13,47]. The renal MG levels in the CSE
-/- mice were
increased significantly in all three age groups (6–8, 14–16, and 20–
22 weeks) when compared to age-matched CSE
+/+ groups
(Fig. 2C). Accompanied by the increased MG levels, renal H2S
levels were significantly decreased in all three age groups (Fig. 2D);
further supporting our hypothesis that MG is up-regulated in the
presence of inadequate H2S.
FBPase is the rate-limiting enzyme in the gluconeogenic
pathway and catalyzes the conversion of F-1,6-P to F-6-P [36].
There are two main isoforms of FBPase, FBPase-1 or liver FBPase,
which is predominant in the liver and kidney [20,36,37], and
FBPase-2 or muscle FBPase, which is predominant in skeletal
muscle [48]. We observed lower activity of total FBPase in kidneys
of 6-22 week-old CSE
–/– mice (Fig. 3A). The lower FBPase activity
appears likely due to the down-regulation of the mRNA levels of
FBPase-1 (Fig. 3B), and to a lesser extent, the down-regulation of
FBPase-2 (Fig. 3C). As such, the decreased FBPase activity was
accompanied by lower levels of its product, F-6-P, and higher
levels of its substrate, F-1,6-P (Figs. 4A and B, respectively). To
rule out possible interference from the glycolytic system, PFK
activity, the enzyme responsible for the conversion of F-6-P to F-
1,6-P, were measured. No changes in PFK activity were observed
(Fig. 4D). These observations suggest that the down-regulation of
FBPase was mainly responsible for the increased MG levels in
renal tissues of CSE
-/- mice. A suppressed gluconeogenic system
with increased MG formation in CSE
-/- mice is not only limited to
the kidney. The mRNA levels of FBPase-1 and -2 were also down-
regulated in aorta extracts from CSE
-/- mice (Figs. 6A and B,
respectively).
The gene transcription of FBPase, along with PEPCK and
ERRa, can be induced by PGC-1a [21]. PGC-1a is a critical
regulator of genes related to energy metabolism [22]. As well,
PGC-1a, along with ERRa, is abundant in human kidney,
skeletal muscle, or tissues with high metabolic demand [49].
Interestingly, the endogenous gasotransmitters, NO [24] and CO
[25], were shown to increase PGC-1a expression levels. In line
with these previous observations, we show here for the first time
that decreased H2S level in renal tissues (Fig. 2D) led to decreased
PGC-1a gene expression (Fig. 5A), which most likely resulted in
significantly lowered FBPase-1 and -2 mRNA levels and impaired
FBPase activity in renal tissues of 6-22 week-old CSE
–/– mice
(Fig. 3). In fact, both PEPCK and ERRa mRNA levels were also
decreased in these renal tissues (Figs. 5B and C, respectively).
Theoretically, decreased gene expression of PEPCK would
reduce the formation of DHAP and GA3P, resulting in decreased
MG formation. Our data of higher levels of DHAP, GA3P, and
MG in renal tissues of CSE
-/- mice further indicate that it is the
specific PGC-1a-FBPase pathway, rather than PGC-1a-PEPCK
pathway, that contributes to the enhanced MG formation in these
CSE deficient mice. In correlation to these findings in the mice,
we have demonstrated that administration of 30 and 50 mM
NaHS induced an increase in the mRNA expression levels of
both PGC-1a and FBPase-1 in rat A-10 cells (Figs. 7A and B,
respectively). Additionally, we have also observed a significant
increase in FBPase-2 and ERRa mRNA levels in 50 mMN a H S -
treated A-10 cells (Figs. 7C and D, respectively), further
supporting the phenomenon of the involvement of H2S in the
regulation of PGC-1a-FBPase pathway. Further molecular study
is needed to determine how H2S regulates the gene transcription
of PGC-1a.
Our studies demonstrated that low levels of endogenous H2Si n
plasma and renal tissues from CSE
–/– mice (Figs. 2B and D,
Figure 8. The regulatory effect of H2S on the direction of renal gluconeogenesis. Panel A: Gluconeogenesis with normal level of
endogenous H2S. Panel B: Gluconeogenesis with lower level of endogenous H2S. AGEs: advanced glycation endproducts; DHAP: dihydroxyacetone
phosphate; F-1,6-P: fructose-1,6-phosphate; F-6-P: fructose-6-phosphate; FBPase: fructose-1,6-bisphosphatase; G-6-P: glucose-6-phosphate; GA3P:
glyceraldehyde 3-phosphate; H2S: hydrogen sulfide; MG: methylglyoxal; PGC-1a: peroxisome proliferator-activated receptor-c coactivator-1a.
doi:10.1371/journal.pone.0029592.g008
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regulator of energy metabolism, along with some of its
downstream targets, ERRa, PEPCK, and FBPase-1 and -2 in
renal tissues (Fig. 8). Because the major unidirectional gluconeo-
genic enzymes, PEPCK and FBPase, are down-regulated,
circulating glucose level is lowered. The decreased FBPase activity
in the kidney of CSE
-/- mice encouraged the accumulation of MG
precursors, DHAP and GA3P, which enhanced the formation of
MG in both renal tissues and in the circulation. Henceforth,
reduced endogenous H2S production attributes to the down-
regulated PGC-1a-FBPase signaling pathway in mice lacking the
CSE gene. As such, H2S redirects the gluconeogenesis process in
the kidney from making glucose to producing MG, and sets up the
balancing point between glucose and MG levels. The latter is likely
exerting an important impact on renal functions.
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